Year: 2021
Type: letter
Abstract: We read with interest the study by Heldman and colleagues 1 showing that, similar to the trends observed in the general population, mortality in solid organ transplant (SOT) recipients with COVID-19 significantly declined over time.Within the limitations associated with the study's retrospective nature, this finding supports the concept that advances in care and COVID-19 therapies improved outcomes in SOT recipients.The accompanying editorial of this article 2 questions whether mortality in SOT is, in fact, lower than in the general population.This is an intriguing question, based on the hypothesis that chronic immunosuppression limits the detrimental effects of the uncontrolled anti-SARS-CoV2 response, including "cytokine storm" and
DOI: 10.1111/ajt.16942
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,300
OpenAlex ID: W4206702726
